Vestcor Inc’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Vestcor Inc’s Portfolio NAMSW Stock Details NAMSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Hold	6,666	–	–	﹤0.01%	1096
2026 Q1	$131K	Sell	6,666 -2,966	-31%	-$61.7K	﹤0.01%	1095
2025 Q4	$239K	Hold	9,632	–	–	0.01%	924
2025 Q3	$165K	Hold	9,632	–	–	﹤0.01%	1011
2025 Q2	$77K	Hold	9,632	–	–	﹤0.01%	1081
2025 Q1	$91K	Hold	9,632	–	–	﹤0.01%	1068
2024 Q4	$137K	Hold	9,632	–	–	﹤0.01%	1051
2024 Q3	$67K	Hold	9,632	–	–	﹤0.01%	1085
2024 Q2	$91K	Hold	9,632	–	–	﹤0.01%	1068
2024 Q1	$106K	Hold	9,632	–	–	﹤0.01%	1088
2023 Q4	$30K	Hold	9,632	–	–	﹤0.01%	1157
2023 Q3	$18K	Hold	9,632	–	–	﹤0.01%	1205
2023 Q2	$20K	Hold	9,632	–	–	﹤0.01%	967
2023 Q1	$18K	Hold	9,632	–	–	﹤0.01%	1085
2022 Q4	$8K	Buy	+9,632	New	+$7.93K	﹤0.01%	1174

Other funds holding NAMSW

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vestcor Inc's NAMSW Position: Q2 2026 in Review

Vestcor Inc held its NewAmsterdam Pharma Warrant (NAMSW) position steady in Q2 2026 at 6,666 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

Vestcor Inc first reported a position in NAMSW in Q4 2022 and has held it in 15 quarters since. The position peaked at $239K in Q4 2025. 9 funds tracked by Wall St. Rank hold NAMSW as of Q2 2026.

Vestcor Inc held 6,666 shares of NewAmsterdam Pharma Warrant worth $143K as of Q2 2026.
Vestcor Inc left its NewAmsterdam Pharma Warrant share count unchanged in Q2 2026.
NewAmsterdam Pharma Warrant made up ﹤0.01% of Vestcor Inc's portfolio in Q2 2026, its #1096 holding.
Vestcor Inc first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 15 quarters since.
Vestcor Inc's NewAmsterdam Pharma Warrant position peaked at $239K in Q4 2025.
9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.